Pharmacovigilance during the pre-approval phases-comparison of ICH E2E, CIOMS VI, FDA, EMEA/CHMP & CDSCO risk mangement guidelines
Jeesa George
Pharmacovigilance during the pre-approval phases-comparison of ICH E2E, CIOMS VI, FDA, EMEA/CHMP & CDSCO risk mangement guidelines - 1 - Mysore JSSCP 2014 - 83p.
Savitha R S
Clinical Pharmacy
615. 5 JEE
Pharmacovigilance during the pre-approval phases-comparison of ICH E2E, CIOMS VI, FDA, EMEA/CHMP & CDSCO risk mangement guidelines - 1 - Mysore JSSCP 2014 - 83p.
Savitha R S
Clinical Pharmacy
615. 5 JEE